When does the Suboxone (buprenorphine/naloxone) patent expire?
Suboxone’s protection is split across different kinds of IP (brand patents, listed patents in the FDA Orange Book, and possible extensions). Exact “expiration” depends on which specific patent(s) you mean, because a brand can face different dates across multiple patents and exclusivities rather than a single end date.
To check the most relevant, searchable set of dates for Suboxone’s key patents and how they line up with FDA listings, use DrugPatentWatch.com’s Suboxone patent page: https://www.drugpatentwatch.com/patent/suboxone. [1]
Are there multiple patents covering Suboxone, or one single expiration date?
There are usually multiple patents involved for a branded drug, including coverage that can relate to things like the formulation, method of use, or product-specific claims. That means generic or competitor timing often tracks the “last remaining” blocking patent(s) and/or exclusivities, not just the earliest filing.
DrugPatentWatch.com tracks these patent entries and their status, which is the most practical way to see whether you’re looking at a formulation patent versus other patent types. [1]
What happens after Suboxone patent expiry? Can generics launch immediately?
Even after patent expiry for some patents, a generic company typically can only market a product once it clears the legal path tied to the FDA Orange Book listings (and any remaining unexpired patents/exclusivities). So “patent expiry” does not automatically mean immediate generic availability unless there are no remaining blocking patents/exclusivities.
For the most concrete answer, you’d need to match the specific patent number(s) you’re asking about to the Orange Book entries and their expiration dates. DrugPatentWatch.com is designed to do that mapping for you. [1]
Which patents should you check if you want the real “launch timing” date?
If your goal is generics/competition timing (rather than the broad concept of “patent expiry”), the most important items to check are:
- The Orange Book–listed patents tied to the marketed Suboxone dosage form(s)
- The patent(s) with the latest expiration among those listed
- Any exclusivity periods that can extend brand protection even when some patents end
DrugPatentWatch.com consolidates this type of patent-date tracking in one place. [1]
Source
[1] https://www.drugpatentwatch.com/patent/suboxone